Modern Healthcare News
 
RSS feed

Pfizer news and information

Magazine
Tax reform fears driving Big Pharma mergers
By Beth Kutscher | July 19, 2014 | Print Magazine Print Magazine Subscription Details
The rumblings that corporate tax reform will close favorable loopholes for pharmaceutical and biotechnology companies are getting louder, fueling a rush of high-dollar cross-border deals.
FULL STORY »
 

Information
Pfizer withdraws spurned offer for AstraZeneca
By Associated Press | May 26, 2014
Pfizer said Monday that it does not intend to make a takeover offer for British drugmaker AstraZeneca, pulling the plug for now on what would have been the largest deal in the industry's history.
FULL STORY »
 

Magazine
Drug prices spotlighted in AstraZeneca deal
By Beth Kutscher | May 24, 2014 | Print Magazine Print Magazine Subscription Details
With a May 26 deadline looming, British drug giant AstraZeneca is holding firm in its refusal to accept a $119 billion offer from Pfizer to create the world's largest pharmaceutical company.
FULL STORY »
 

News
AstraZeneca holding firm against Pfizer's advances
By Beth Kutscher | May 23, 2014 | Basic Web Basic Web Subscription Details
With a May 26 deadline looming, British drug giant AstraZeneca is holding firm in its refusal to accept a $119 billion offer from rival Pfizer to create the world's largest pharmaceutical company. The record-setting offer is just one of a slew of mega-deals this year in the pharmaceutical and...
FULL STORY »
 

Information
AstraZeneca rejects Pfizer's 'final' $116B bid
By USA Today | May 19, 2014
British drug maker AstraZeneca rejected Monday what its New York-based rival Pfizer called over the weekend its "final" takeover offer.
FULL STORY »
 


Advertisement | View Media Kit

Magazine
Pfizer faces lawsuits that claim Lipitor caused diabetes
By Joe Carlson | May 17, 2014 | Print Magazine Print Magazine Subscription Details
Several hundred women are suing Pfizer in federal court, alleging the company knew that women taking Lipitor faced an increased risk of developing Type 2 diabetes and that Pfizer's warning label did not clearly describe that risk.
FULL STORY »
 

Information
AstraZeneca rejects sweetened Pfizer takeover bid
By Associated Press | May 02, 2014
Pharmaceutical company AstraZeneca on Friday flatly rejected drug maker Pfizer's sweetened takeover bid — worth $106 billion — just hours after it was levelled, describing it as inadequate.
FULL STORY »
 

Information
AstraZeneca shares soar on Pfizer interest
By Associated Press | April 28, 2014
Shares in Anglo-Swedish drugmaker AstraZeneca jumped 15% on Monday after U.S. pharmaceutical company Pfizer said it offered to buy the company for around $100 billion.
FULL STORY »
 

News
Novartis overtakes Pfizer as top drug company
By Michael Sandler | April 13, 2014 | Basic Web Basic Web Subscription Details
A robust sales year for three of Novartis' medications allowed the firm to pass reeling Pfizer for the top spot on Modern Healthcare's annual list of largest publicly traded pharmaceutical companies.
FULL STORY »
 

Data Center
25 Largest publicly traded pharmaceutical companies
April 12, 2014
A list of the largest publicly traded pharmaceutical companies, ranked by 2013 revenue reported to the U.S. Securities and Exchange Commission and other sources. Source: Modern Healthcare reporting. Published April 14, 2014. p. 32
FULL STORY »
 

Search ModernHealthcare.com:


 

Switch to the new Modern Healthcare Daily News app

For the best experience of ModernHealthcare.com on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.